You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BSEM Exercise Disclosure
Smith-van Vurst Andrew · SEC Form 4 · Filed Oct 9, 2026
Exercise
Calculated transaction value
$0
Smith-van Vurst Andrew Chief Operating Officer
BSEM
Transaction date
Oct 7, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed 2 days later
BSEM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Options (Right to Buy) on Common Stock
- Quantity / price
- 250,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-419153
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$500K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Biostem Technologies, Inc. BSEM Current | Exercise | Oct 7, 2026 | $0 |
| Biostem Technologies, Inc. BSEM | Exercise | Oct 7, 2026 | $500K |